Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients

MLA

Allen, Br, et al. “Systemic Exposure, Tolerability, and Efficacy of Pimecrolimus Cream 1% in Atopic Dermatitis Patients.” Archives of Disease in Childhood, vol. 88, no. 11, Nov. 2003, p. 969. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.111264933&authtype=sso&custid=ns315887.

APA

Allen, B., Lakhanpaul, M., Morris, A., Lateo, S., Davies, T., Scott, G., Cardno, M., Ebelin, M.-E., Burtin, P., & Stephenson, T. (2003). Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients. Archives of Disease in Childhood, 88(11), 969.

Chicago

Allen, Br, M Lakhanpaul, A Morris, S Lateo, T Davies, G Scott, M Cardno, M-E Ebelin, P Burtin, and Tj Stephenson. 2003. “Systemic Exposure, Tolerability, and Efficacy of Pimecrolimus Cream 1% in Atopic Dermatitis Patients.” Archives of Disease in Childhood 88 (11): 969. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.111264933&authtype=sso&custid=ns315887.